From January 1, 2024 to March 31, 2024, the company has repurchased 62,607 shares, representing 2.15% for $0.1 million. With this, the company has completed the repurchase of 315,462 shares, representing 10.37% for $0.57 million under the buyback announced on January 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | +0.54% | -2.61% | +27.15% |
Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.15% | 5.23M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.38% | 31.47B | |
+54.44% | 25.24B | |
-12.60% | 15.82B | |
-9.12% | 11.96B | |
-15.54% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.